MedReleaf and Ehave announced a new partnership to clinically assess and optimize cannabis-based therapies for treating a variety of health conditions.
The companies intend to achieve that with a new patient intake system built by integrating Ehave’s mental health information software with MedReleaf’s patient and physician dashboard. MedReleaf is also a licensed producer of medical cannabis.
Hospitals and practices already are gearing up to treat patients with cannabis and could potentially use the system to determine the efficacy of such regimens.
[Also: Epic, CVS hope analytics partnership will rein in drug prices]
Customers can use the dashboard, in fact, to establish baseline patient assessments and track patient-reported symptoms by incorporating a broad panel of clinically validated surveys into a single digital portal.
This first tool will be integrated with future compliance and reporting offerings co-developed by Ehave and MedReleaf designed to empower patients in their treatment plans, help both patients and healthcare practitioners to encourage treatment compliance, and verify treatment outcomes in a reliable and objective manner, the companies said.
[Also: Predictive analytics can spot patients not taking their medicine]
Ehave CEO Prateek Dwivedi said in a statement that the companies intend to objectively capture data about how patients with various conditions respond to therapies and, in turn, incorporate validated or novel surveys into formats including a clinician portal, video games, digital platforms or customized apps.
MedReleaf CEO Neil Closner added that the companies are focused on improving patient outcomes by tapping data-driven technology to ultimately validate the efficacy of treating patients with cannabis.
The partnership also provides a pathway to clinical validation for emerging treatment modalities such as medical cannabis, where efficacious dosing and administration remains to be established by the clinician and regulatory standards, Dwivedi added.
Twitter: @SiwickiHealthIT
Email the writer: bill.siwicki@himssmedia.com
